Protein Conformation

Events
Harnessing TIGIT Checkpoint Inhibitor Therapies as the Next Pillar of Frontline Cancer Treatments (4)
Partner Content

Protein Misfolding Drug Discovery Summit

With protein misfolding and aggregation prevalent in neurodegeneration, cancer, metabolic and ophthalmic diseases, the unmet clinical need presents huge opportunity to accelerate the discovery and